Dr David John Mccann, MD | |
11 Friendship St, Newport Emergency Physicians Inc, Newport, RI 02840-2209 | |
(401) 845-1594 | |
Not Available |
Full Name | Dr David John Mccann |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 11 Friendship St, Newport, Rhode Island |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245454883 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD12293 (Rhode Island) | Primary |
Entity Name | The William W Backus Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467517235 PECOS PAC ID: 0749170645 Enrollment ID: O20040316000739 |
News Archive
A new study shows that a sleep disorder may be a sign of dementia or Parkinson's disease up to 50 years before the disorders are diagnosed. The research is published in the July 28, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology.
A gas that was formerly known for its noxious qualities could help people with diabetes recover from common heart and blood vessel complications, concludes research led by the University of Exeter Medical School.
Licensed pesticide applicators who used chlorinated pesticides on more than 100 days in their lifetime were at greater risk of diabetes, according to researchers from the National Institutes of Health (NIH). The associations between specific pesticides and incident diabetes ranged from a 20 percent to a 200 percent increase in risk, said the scientists with the NIH's National Institute of Environmental Health Sciences (NIEHS) and the National Cancer Institute (NCI).
Titanium-based materials are widely used in medical implant technology. Coating the surface of titanium materials with biologically active molecules has recently shown promise to improve how cells adhere to implants and promote tissue regeneration. The mechanisms behind how peptides stick to titanium, however, are not fully understood.
Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David John Mccann, MD 62 Douglas Dr, Saunderstown, RI 02874-1951 Ph: (617) 320-0766 | Dr David John Mccann, MD 11 Friendship St, Newport Emergency Physicians Inc, Newport, RI 02840-2209 Ph: (401) 845-1594 |
News Archive
A new study shows that a sleep disorder may be a sign of dementia or Parkinson's disease up to 50 years before the disorders are diagnosed. The research is published in the July 28, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology.
A gas that was formerly known for its noxious qualities could help people with diabetes recover from common heart and blood vessel complications, concludes research led by the University of Exeter Medical School.
Licensed pesticide applicators who used chlorinated pesticides on more than 100 days in their lifetime were at greater risk of diabetes, according to researchers from the National Institutes of Health (NIH). The associations between specific pesticides and incident diabetes ranged from a 20 percent to a 200 percent increase in risk, said the scientists with the NIH's National Institute of Environmental Health Sciences (NIEHS) and the National Cancer Institute (NCI).
Titanium-based materials are widely used in medical implant technology. Coating the surface of titanium materials with biologically active molecules has recently shown promise to improve how cells adhere to implants and promote tissue regeneration. The mechanisms behind how peptides stick to titanium, however, are not fully understood.
Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.
› Verified 3 days ago
Charles Leigh Stengel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Friendship St, Newport, RI 02840 Phone: 401-845-1593 Fax: 401-847-0650 | |
Mark Conrad Muetterties, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Friendship St, Newport, RI 02840 Phone: 401-845-1593 Fax: 401-847-0650 | |
James B Gleason, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Friendship St, Newport, RI 02840 Phone: 401-845-1593 Fax: 401-847-0650 | |
Stuart Jay Spitalnic, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Friendship St, Newport, RI 02840 Phone: 401-845-1593 Fax: 401-847-0650 | |
Gita Subramanian Pensa, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11 Friendship St, Newport, RI 02840 Phone: 401-845-1593 Fax: 401-847-0650 | |
Keri Tilman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Friendship St, Newport, RI 02840 Phone: 401-845-1593 Fax: 401-847-0650 |